Andreas G. Tzakis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andreas G. Tzakis has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
D. Weppler
University of Miami Miller School of Medicine, Miami, United States
5 shared publications- Phillip Ruiz
Histocompatibility and Immunology Laboratory The Mount Sinai Hospital New York New York USA
4 shared publications - Tomoaki Kato
Columbia Center of Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA; Department of Surgery, Columbia University/New York-Presbyterian Hospital, New York, New York, USA
4 shared publications D. Levi
University of Miami Miller School of Medicine, Miami, United States
3 shared publications- Gennaro Selvaggi
Department of Surgery, Division of Transplant Surgery University of Miami/Jackson Health System Miami Florida USA
3 shared publications - Seigo Nishida
Division of Transplant Surgery, Westchester Medical Center, Valhalla, NY
3 shared publications
Latest Publications
- Open Access
- 14 December 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (5) , 1699-1704
Life underneath the VCA umbrella: Perspectives from the US Uterus Transplant Consortium
- 14 December 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (5) , 1699-1704
Open AccessLife underneath the VCA umbrella: Perspectives from the US Uterus Transplant Consortium
- Open Access
- 7 May 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (12) , 3319-3325
Guidelines for standardized nomenclature and reporting in uterus transplantation: An opinion from the United States Uterus Transplant Consortium
- 7 May 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (12) , 3319-3325
Open AccessGuidelines for standardized nomenclature and reporting in uterus transplantation: An opinion from the United States Uterus Transplant Consortium
- 1 March 2018
- Published by Elsevier in Fertility and Sterility
- Vol. 109 (3) , e21-e22
IVF cycle characteristics in patients approved for uterine transplantation
- 1 March 2018
- Published by Elsevier in Fertility and Sterility
- Vol. 109 (3) , e21-e22
IVF cycle characteristics in patients approved for uterine transplantation
- Open Access
- 15 April 2013
- Published by Wiley in Journal of Transplantation
- Vol. 2013, 1-5
Preoperative Comorbidity Correlates Inversely with Survival after Intestinal and Multivisceral Transplantation in Adults
We investigated the relationship between preoperative comorbidity and postoperative survival after intestinal transplantation. Each patient received a score for preoperative comorbidity. Each comorbidity was given a score based on the degree it impaired function (score range 0–3). A total score was derived from the summation of individual comorbidity scores. Patients (72 adults (M : F, 33 : 39)) received an isolated intestinal graft (27) or a cluster graft (45). Mean (standard deviation) survival was 1501 (1444) days. The Kaplan-Meier analysis revealed a significant inverse association between survival and comorbidity score (logrank test for trend, ). Patients grouped into comorbidity scores of 0 and 1, 2 and 3, 4 and 5, 6, and above had hazard ratios (95% confidence intervals) for death (compared to group 0 + 1), which increased with comorbidity scores: 1.945 (0.7622–5.816), 5.075 (3.314–36.17), and 13.77 (463.3–120100), respectively, (). Receiver-operator curves at 1, 3, 5, and 10 years postoperative had “C” statistics of 0.88, 0.85, 0.88, and 0.92, respectively. When evaluating patients for transplantation, the degree of comorbidity should be considered as a major factor influencing postoperative survival.
- 15 April 2013
- Published by Wiley in Journal of Transplantation
- Vol. 2013, 1-5
Open AccessPreoperative Comorbidity Correlates Inversely with Survival after Intestinal and Multivisceral Transplantation in Adults
We investigated the relationship between preoperative comorbidity and postoperative survival after intestinal transplantation. Each patient received a score for preoperative comorbidity. Each comorbidity was given a score based on the degree it impaired function (score range 0–3). A total score was derived from the summation of individual comorbidity scores. Patients (72 adults (M : F, 33 : 39)) received an isolated intestinal graft (27) or a cluster graft (45). Mean (standard deviation) survival was 1501 (1444) days. The Kaplan-Meier analysis revealed a significant inverse association between survival and comorbidity score (logrank test for trend, ). Patients grouped into comorbidity scores of 0 and 1, 2 and 3, 4 and 5, 6, and above had hazard ratios (95% confidence intervals) for death (compared to group 0 + 1), which increased with comorbidity scores: 1.945 (0.7622–5.816), 5.075 (3.314–36.17), and 13.77 (463.3–120100), respectively, (). Receiver-operator curves at 1, 3, 5, and 10 years postoperative had “C” statistics of 0.88, 0.85, 0.88, and 0.92, respectively. When evaluating patients for transplantation, the degree of comorbidity should be considered as a major factor influencing postoperative survival.
- Open Access
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 131
Campath-1H Induction in Adult Liver Transplantation: Long-Term Follow Up of 300 Patients
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 131
Open AccessCampath-1H Induction in Adult Liver Transplantation: Long-Term Follow Up of 300 Patients
- Open Access
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 229
Liver Grafts Contain a Large Number of CD52 Negative Natural Killer Cells: Role for Infections after Liver Transplantation with Alemtuzumab Induction
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 229
Open AccessLiver Grafts Contain a Large Number of CD52 Negative Natural Killer Cells: Role for Infections after Liver Transplantation with Alemtuzumab Induction
- Open Access
- 1 January 2011
- Published by Wiley in Journal of Transplantation
- Vol. 2011, 1-12
Human Liver Cells Expressing Albumin and Mesenchymal Characteristics Give Rise to Insulin-Producing Cells
Activation of the pancreatic lineage in the liver has been suggested as a potential autologous cell replacement therapy for diabetic patients. Transcription factors-induced liver-to-pancreas reprogramming has been demonstrated in numerous species bothin vivoandin vitro. However, human-derived liver cells capable of acquiring the alternate pancreatic repertoire have never been characterized. It is yet unknown whether hepatic-like stem cells or rather adult liver cells give rise to insulin-producing cells. Using anin vitroexperimental system, we demonstrate that proliferating adherent human liver cells acquire mesenchymal-like characteristics and a considerable level of cellular plasticity. However, using a lineage-tracing approach, we demonstrate that insulin-producing cells are primarily generated in cells enriched for adult hepatic markers that coexpress both albumin and mesenchymal markers. Taken together, our data suggest that adult human hepatic tissue retains a substantial level of developmental plasticity, which could be exploited in regenerative medicine approaches.
- 1 January 2011
- Published by Wiley in Journal of Transplantation
- Vol. 2011, 1-12
Open AccessHuman Liver Cells Expressing Albumin and Mesenchymal Characteristics Give Rise to Insulin-Producing Cells
Activation of the pancreatic lineage in the liver has been suggested as a potential autologous cell replacement therapy for diabetic patients. Transcription factors-induced liver-to-pancreas reprogramming has been demonstrated in numerous species bothin vivoandin vitro. However, human-derived liver cells capable of acquiring the alternate pancreatic repertoire have never been characterized. It is yet unknown whether hepatic-like stem cells or rather adult liver cells give rise to insulin-producing cells. Using anin vitroexperimental system, we demonstrate that proliferating adherent human liver cells acquire mesenchymal-like characteristics and a considerable level of cellular plasticity. However, using a lineage-tracing approach, we demonstrate that insulin-producing cells are primarily generated in cells enriched for adult hepatic markers that coexpress both albumin and mesenchymal markers. Taken together, our data suggest that adult human hepatic tissue retains a substantial level of developmental plasticity, which could be exploited in regenerative medicine approaches.
- Open Access
- 23 December 2010
- Published by Wiley in International Journal of Endocrinology
- Vol. 2010, 1-5
Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation
Propylthiouracil- (PTU-) induced hepatotoxicity is rare but potentially lethal with a spectrum of liver injury ranging from asymptomatic elevation of transaminases to fulminant hepatic failure and death. We describe two cases of acute hepatic failure due to PTU that required liver transplantation. Differences in the clinical presentation, histological characteristics, and posttransplant management are described as well as alternative therapeutic options. Frequent monitoring for PTU-induced hepatic dysfunction is strongly advised because timely discontinuation of this drug and implementation of noninvasive therapeutic interventions may prevent progression to liver failure or even death.
- 23 December 2010
- Published by Wiley in International Journal of Endocrinology
- Vol. 2010, 1-5
Open AccessPropylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation
Propylthiouracil- (PTU-) induced hepatotoxicity is rare but potentially lethal with a spectrum of liver injury ranging from asymptomatic elevation of transaminases to fulminant hepatic failure and death. We describe two cases of acute hepatic failure due to PTU that required liver transplantation. Differences in the clinical presentation, histological characteristics, and posttransplant management are described as well as alternative therapeutic options. Frequent monitoring for PTU-induced hepatic dysfunction is strongly advised because timely discontinuation of this drug and implementation of noninvasive therapeutic interventions may prevent progression to liver failure or even death.
- 1 July 2006
- Published by Elsevier in Transplantation Proceedings
- Vol. 38 (6) , 1683-1684
International Grading Scheme for Acute Rejection in Small Bowel Transplantation: Implementation and Experience at the University of Miami
- 1 July 2006
- Published by Elsevier in Transplantation Proceedings
- Vol. 38 (6) , 1683-1684
International Grading Scheme for Acute Rejection in Small Bowel Transplantation: Implementation and Experience at the University of Miami
- 1 March 2005
- Published by Elsevier in Transplantation Proceedings
- Vol. 37 (2) , 1375-1378
Abrogation of the Alloreactive Responses of Cadaveric Donor Intestinal Lymphocytes by Intraoperative Campath-1H Exposure
- 1 March 2005
- Published by Elsevier in Transplantation Proceedings
- Vol. 37 (2) , 1375-1378
Abrogation of the Alloreactive Responses of Cadaveric Donor Intestinal Lymphocytes by Intraoperative Campath-1H Exposure